Abbott Labs’ fourth-quarter sales top estimates amid strong medical-device demand
Abbott Laboratories’ stock ABT, fell 2% premarket on Wednesday after the healthcare-products company reported fourth-quarter sales that topped expectations amid strength in its medical-device and nutrition segments, even as COVID-test sales continued to plunge. The company reported fourth-quarter…
#abbottlaboratories #abt #freestylelibre #abbott #robertford #jpmorgan #freestylelibre2plus #novonordisksnvo #wegovy #elilillycos